欢 刘

欢 刘 has a wealth of experience in the medical and venture capital fields. In 2021, they were the Director at Redesign Science. From 2019 to 2021, they were an Associate at 吾泰资本, where they were an early-stage venture investor from angel to B round. Her investments of interest included Nucleic Acid Therapeutics, Targeted Protein Degradation, novel drug discovery technologies, artificial intelligence and medical big data based pharmaceutical sciences / disease prevention / chronic disease management. From 2012 to 2019, they were an Intern at the Medical University of South Carolina.

欢 刘 attended Zhejiang University from 2009 to 2013, where they obtained a Bachelor's degree in Pharmacy. From 2013 to 2019, they obtained a Doctoral degree in Pharmaceutical Chemistry from the same university.